We use cookies for a better user experience. Read our Privacy Policy

I Agree

Amniotic Membrane Market Outlook, 2019-2027

Amniotic Membrane Market (Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane; Application: Surgical Wounds, Ophthalmology, Others; End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Amniotic Membrane Dressings Reduce Infection Transfer in Burn Patients

Chronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns. Hence, healthcare industries are increasing awareness about amniotic membranes (AM), since these membranes have gained the approval of many health commissions across various countries.

Healthcare providers in the amniotic membrane market are increasingly using fresh amniotic membranes as dressings on burn areas. It has been found that, serology and virology tests validate the use of frozen amnion membrane dressings to minimize the risks of infection transfer. Companies in the amniotic membrane market are increasing the availability of amnion membranes to facilitate the reepithelization of burn wounds. Incremental opportunities related to burn wounds are likely to grow, since the overall surgical wounds domain accounts for the highest revenue amongst all applications in the amniotic membrane market, with a predicted value of ~US$ 1.2 billion by 2027.

The growing trend of amniotic membranes enriched with stem cells is gaining traction in the healthcare landscape. This trend is anticipated to grow even further, since it has been found that, amniotic membrane dressings significantly reduce pain in burn patients.

amniotic membrane market infographic

To know the scope of our report Get a Sample on Amniotic Membrane Market

Companies Innovate in Stem Cell-induced hAM for Cardiac Tissue Regeneration

There is growing demand for human amniotic membranes (hAM) for cardiac tissue regeneration. Hence, healthcare companies in the amniotic membrane market fostering innovation in human-induced pluripotent stem cell (hiPSC)-derived cardiac muscle cells for successful cardiac tissue regeneration. This technique is pervasively becoming a treatment alternative to gelatin-based 3D matrix matrigel protein.

Heart attacks can lead to necrosis of the cardiac tissue. This trend has become a driver for the amniotic membrane market, since increasing rates of heart failures have led to several deaths, worldwide. Individuals are becoming increasingly aware about hAM. Hence, companies in the amniotic membrane market are increasing the availability of hAM in hospitals and ambulatory surgical centers to aid successful regeneration of injured cardiac tissue.

Healthcare companies are focusing on innovation regarding the combination of stem cells and synthetic materials for cardiac tissue regeneration. Decellularized biological matrices are also emerging as a useful alternative for tissue regeneration.

Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain

Foot pain is one of the most common orthopedic complaints in the healthcare landscape. To cater to this prevalent health condition, healthcare industries are developing improved amniotic allografts to reduce joint and soft tissue pain. The introduction of amniotic allografts has helped reduce pain and enhance healing in patients suffering from foot and ankle pain.

Growing incidence of repeated trauma and joint pain in the feet has triggered the demand for amniotic allografts. Healthcare providers are providing relief to patients after several clinical trials through musculoskeletal ultrasound, electromyography and computerized tomography scans. Amniotic allografts are becoming increasingly popular amongst patients, since this technique provides long-term relief, unlike the conventional non-operative management of joint pain.

Get a glimpse of the in-depth analysis through our Report Brochure

Locally available amnion mesenchymal cell injections are creating incremental opportunities for healthcare companies, since these injections help in the healing of injured peripheral nerves.

HAAM-based Approach Becomes Increasingly Suitable for Treatment of Skin Wounds

The lower third of the nose is one of the most important cosmetic units as far as the face is concerned. However, reconstruction techniques for the same remain a challenge for healthcare industries in the amniotic membrane space.

Human acellular amniotic membrane (HAAM) implantation serves as an effective approach for lower third nasal reconstruction. Companies in the amniotic membrane market are carrying out extensive investigations to closely study this biomaterial-based strategy. However, in many cases, HAAM leads to full-thickness defects after the surgical procedure. Lack of research studies make it unclear whether the locations of the wound affect the healing potential of HAAM. To overcome these challenges, healthcare industries in the amniotic membrane market are increasing efforts to establish a standardized process for HAAM that can aid its adoption for future clinical use.

Altogether, HAAM is found to have a promising approach for treating various skin defects. Hence, healthcare industries are increasing its application in the amniotic membrane market for repairing skin wounds. They are increasing their R&D efforts to study the safety and efficacy of HAAM for burn wounds and diabetic foot ulcers.

amniotic membrane market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The amniotic membrane market is highly consolidated in nature, with only four major players accounting for ~70% of the market share. Companies are increasing their presence in inorganic strategies such as commercializing their product portfolios. For instance, in August 2018, MiMedx - a leader in placental-based products, revealed that it had received regulatory approval to commercialize its product portfolio in dehydrated human amnion/chorion membrane (dHACM) products in Australia.

However, complications associated with amniotic membranes, such as post AM transplantation infection and premature degeneration, are likely to hamper market growth. To win over these hurdles, companies should increase R&D related to the orientation of AM with useful techniques such as sutureless AM in clinical-based setting.

Amniotic Membrane Market and Report Description

  • Cryopreserved amniotic membranes and lyophilization amniotic membranes are the two types of amniotic membranes are used in wound healing and ophthalmology applications.
  • Amniotic membrane transplantation is used as a graft or dressing in different surgical procedures to reduce inflammation and promote wound healing. Cryopreserved amniotic membranes are primarily used in ocular surface surgeries, as cryopreservation preserves the biological structure, including the cells and other organelles by cooling them to very low temperatures.
  • Amniotic membranes are used in ophthalmology to reconstruct the ocular surface after various surgical procedures, as a graft for ocular surface melts, or as a bandage to promote healing in cases of persistent epithelial defects or ocular surface inflammation. The application of amniotic membranes in ophthalmology has increased significantly in the past few years.
  • Amniotic membrane transplantation is used in surgical wounds as a graft or dressing material in different surgical subspecialties.
  • Rise in the number of trauma cases, burn injuries, and ophthalmic disorders are projected to drive the global amniotic membrane market during the forecast period.
  • The global amniotic membrane market is projected to expand at a healthy CARG of ~10% from 2019 to 2027. 

Global Amniotic Membrane Market: Drivers

  • Increase in number of accident and trauma cases drive the global amniotic membrane market. Human amniotic membrane has wide range of applications including treatment of ocular surface disorders and wound healing. According to the World Health Organization (WHO), an estimated 180,000 deaths are caused by burns each year, with majority occurring in low- and middle-income countries and two third in Africa and Southeast Asia.
  • Amniotic membrane (AM) transplantation as a permanent surgical graft has shown to promote epithelialization and reduce inflammation, scarring, and neovascularization. Amniotic membranes are also used as temporary patch or biological bandage for acute chemical burns.
  • Governments of several countries fund stem cell/regenerative medicine studies. This factor propels the global amniotic membrane market.
  • Based on the Government Accountability Office data, approximately US$ 2.89 Bn was invested by seven federal agencies for regenerative medicine research from 2012 to 2014. Of this, 88% was invested by the National Institutes of Health. Government initiatives to spread awareness about usage of amniotic membrane is likely to propel the global amniotic membrane market in the near future.
  • Rise in government initiatives and continuous funding is expected to boost the growth of the global amniotic membrane market 

Global Amniotic Membrane Market: Key Segments

  • The cryopreserved amniotic membrane dominated the global amniotic membrane market in 2018. Cryopreservation preserves biological constructs such as cells and organelles by cooling the sample to a very low temperature, and cryopreserved amniotic membranes aid wound healing.
  • The surgical wounds segment dominated the global amniotic membrane market in 2018. Rise in the number of sport- and fall-related injuries is expected to drive the growth of the segment over the period of forecast. It is anticipated to create high incremental opportunity in the global amniotic membrane market during the forecast period.
  • Rise in the number of accident cases and trauma injuries in several countries makes hospitals a major end user of the amniotic membrane market. Growth of the segment can be attributed to rise in the rate of hospitalization and wide range of services offered at a single site. 

Global Amniotic Membrane Market: Competition Analysis

  • The global amniotic membrane market report concludes with the company profiles section that includes key information about the major players in the market.
  • Leading players analyzed in the amniotic membrane market report are
    • Integra LifeSciences
    • MiMedx
    • Skye Biologics, Inc.
    • Katena Products, Inc.
    • Amnio Technology
    • LLC
    • Applied Biologics
    • TissueTech, Inc.
    • Stryker
    • Osiris Therapeutics, Inc.
    • Human Regenerative Technologies
  • Each of these players has been profiled in the global amniotic membrane market report based on parameters such as company overview, financial overview, business strategy, product portfolio, business segment, and recent developments.
  • In February 2017, Integra LifeSciences acquired Derma Sciences to strengthen its tissue regeneration segment. This breakthrough therapy enabled the company to enhance its regenerative tissue product line, and treat a diverse population with wound healing properties.
  • Development of innovative new products through robust R&D, global expansion through wide distribution network, and mergers & acquisitions are key strategies adopted by leading players in the global market. Several companies are focusing on new product launches and mergers & acquisitions on a global level.
  • In August 2018, MiMedx received regulatory approval from the Therapeutics Goods Administration (TGA) in Australia for distributing dehydrated human amnion/chorion membrane (dHACM) products.

Global Amniotic Membrane Market - Segmentation

TMR’s study on the global amniotic membrane market includes information divided into four segments: product, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global amniotic membrane market have been discussed in detail.

Product

Cryopreserved Amniotic Membrane

Lyophilization Amniotic Membrane

Application

Surgical Wounds

Ophthalmology

Others

End User

Hospitals

Ambulatory Surgical Centers

Specialized Clinics

Research Centers & Laboratories

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Amniotic Membrane Market Outlook, 2019-2027

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of amniotic membrane market?

Amniotic membrane market to reach a valuation of ~US$ 2.4 Bn by 2027

What is the anticipated CAGR of the amniotic membrane market in the forecast period?

Amniotic membrane market to expand at a CAGR of ~10% from 2019 to 2027

What are the key driving factors for the growth of the amniotic membrane market?

Amniotic membrane market is driven by increase in research on amniotic membranes as a regenerative medicine

Which is the rising prominent segment in the amniotic membrane market?

The cryopreserved amniotic membrane segment dominated the global amniotic membrane market, and the trend is likely to continue during the forecast period

Who are the key players in the global amniotic membrane market?

Key players in the global amniotic membrane market include Amnio Technology, LLC, Katena Products, Inc., MiMedx, Skye Biologics, Inc., Integra LifeSciences, Applied Biologics

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Amniotic Membrane Market

4. Market Overview

    4.1.  Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1.  Drivers

        4.3.2.  Restraints

        4.3.3.  Opportunities 

    4.4. Global Amniotic Membrane Market Analysis and Forecast, 2017–2027

5. Key Insights

    5.1. Clinical Trial Analysis

    5.2. Regulatory Scenario of Amniotic Membrane Products

    5.3. Reimbursement Scenario of Amniotic Membrane

6. Global Amniotic Membrane Market Analysis and Forecasts, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        6.3.1.  Cryopreserved Amniotic Membrane

        6.3.2.  Lyophilization Amniotic Membrane

    6.4. Global Amniotic Membrane Market Attractiveness, by Product

7. Global Amniotic Membrane Market Analysis and Forecasts, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Amniotic Membrane Market Value (US$) Forecast, by Application, 2017–2027

        7.3.1.  Surgical Wounds

        7.3.2.  Ophthalmology

        7.3.3.  Others

    7.4. Global Amniotic Membrane Market Attractiveness, by Application

8. Global Amniotic Membrane Market Analysis and Forecasts, by End User

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        8.3.1.  Hospitals

        8.3.2.  Ambulatory Surgical Centers

        8.3.3.  Specialized Clinics

        8.3.4.  Research Centers & Laboratories

    8.4. Global Amniotic Membrane Market Attractiveness, by End User

9. Global Amniotic Membrane Market Analysis and Forecasts, by Region

    9.1. Key Findings

    9.2. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region

        9.2.1.  North America

        9.2.2.  Europe

        9.2.3.  Asia Pacific

        9.2.4.  Latin America

        9.2.5.  Middle East & Africa

    9.3. Global Amniotic Membrane Market Attractiveness, by Region

10. North America Amniotic Membrane Market Analysis and Forecast

    10.1. Introduction

    10.2. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        10.2.1. Cryopreserved Amniotic Membrane

        10.2.2. Lyophilization Amniotic Membrane

    10.3. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.3.1. Surgical Wounds

        10.3.2. Ophthalmology

        10.3.3. Others

    10.4. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Specialized Clinics

        10.4.4. Research Centers & Laboratories

    10.5. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Amniotic Membrane Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End User

        10.6.4. By Country 

11. Europe Amniotic Membrane Market Analysis and Forecast

    11.1. Introduction

    11.2. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        11.2.1. Cryopreserved Amniotic Membrane

        11.2.2. Lyophilization Amniotic Membrane

    11.3. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.3.1. Surgical Wounds

        11.3.2. Ophthalmology

        11.3.3. Others

    11.4. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Specialized Clinics

        11.4.4. Research Centers & Laboratories

    11.5. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Amniotic Membrane Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End User

        11.6.4. By Country/Sub-region 

12. Asia Pacific Amniotic Membrane Market Analysis and Forecast

    12.1. Introduction

    12.2. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        12.2.1. Cryopreserved Amniotic Membrane

        12.2.2. Lyophilization Amniotic Membrane

    12.3. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.3.1. Surgical Wounds

        12.3.2. Ophthalmology

        12.3.3. Others

    12.4. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Specialized Clinics

        12.4.4. Research Centers & Laboratories

    12.5. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Amniotic Membrane Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End User

        12.6.4. By Country/Sub-region 

13. Latin America Amniotic Membrane Market Analysis and Forecast

    13.1. Introduction

    13.2. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.2.1. Cryopreserved Amniotic Membrane

        13.2.2. Lyophilization Amniotic Membrane

    13.3. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.3.1. Surgical Wounds

        13.3.2. Ophthalmology

        13.3.3. Others

    13.4. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Specialized Clinics

        13.4.4. Research Centers & Laboratories

    13.5. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Amniotic Membrane Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End User

        13.6.4. By Country/Sub-region 

14. Middle East & Africa Amniotic Membrane Market Analysis and Forecast

    14.1. Introduction

    14.2. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

        14.2.1. Cryopreserved Amniotic Membrane

        14.2.2. Lyophilization Amniotic Membrane

    14.3. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

        14.3.1. Surgical Wounds

        14.3.2. Ophthalmology

        14.3.3. Others

    14.4. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Specialized Clinics

        14.4.4. Research Centers & Laboratories

    14.5. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC 

        14.5.2. South Africa

        14.5.3. Israel

        14.5.4. Rest of Middle East & Africa

    14.6. Middle East & Africa Amniotic Membrane Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End User

        14.6.4. By Country/Sub-region 

15. Competition Landscape

    15.1. Market Share Analysis, by Company, 2018

    15.2. Company Profiles

        15.2.1. Integra LifeSciences

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Company Financials

            15.2.1.3. Growth Strategies

            15.2.1.4. SWOT Analysis

        15.2.2. MiMedx

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Company Financials

            15.2.2.3. Growth Strategies

            15.2.2.4. SWOT Analysis

        15.2.3. Skye Biologics, Inc.

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Growth Strategies

            15.2.3.3. SWOT Analysis

        15.2.4. Katena Products, Inc.

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Growth Strategies

            15.2.4.3. SWOT Analysis

        15.2.5. Amnio Technology, LLC

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Growth Strategies

            15.2.5.3. SWOT Analysis

        15.2.6. Applied Biologics

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Growth Strategies

            15.2.6.3. SWOT Analysis

        15.2.7. TissueTech, Inc.

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Growth Strategies

            15.2.7.3. SWOT Analysis

        15.2.8. Stryker

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Company Financials

            15.2.8.3. Growth Strategies

            15.2.8.4. SWOT Analysis

        15.2.9. Osiris Therapeutics, Inc.

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Company Financials

            15.2.9.3. Growth Strategies

            15.2.9.4. SWOT Analysis

        15.2.10. Human Regenerative Technologies, LLC

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Growth Strategies

            15.2.10.3. SWOT Analysis

List of Tables

Table 01: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 03: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 04: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 06: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 07: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 08: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 10: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 12: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 14: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 15: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 16: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 18: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 20: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 22: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 24: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Amniotic Membrane Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global Amniotic Membrane Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 03: Brand Wise Number of Clinical Trials per Product, 2017

Figure 04: Number of Clinical Trials for Amniotic Membrane Products - Company wise, 2017

Figure 05: Global Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 06: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Cryopreserved Amniotic Membrane, 2017–2027

Figure 07: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Lyophilization Amniotic Membrane, 2017–2027

Figure 08: Global Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027

Figure 09: Global Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 10: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Surgical Wounds, 2017–2027

Figure 11: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2017–2027

Figure 12: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 13: Global Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 14: Global Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 15: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 16: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

Figure 17: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialized Clinics, 2017–2027

Figure 18: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Research Centers & Laboratories, 2017–2027

Figure 19: Global Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027

Figure 20: Global Amniotic Membrane Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Amniotic Membrane Market Attractiveness Analysis, by Region, 2019–2027

Figure 22: North America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 23: North America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 24: North America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027

Figure 25: North America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 26: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 27: North America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 28: North America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027

Figure 29: North America Amniotic Membrane Market Value Share Analysis, by Country, 2018 and 2027

Figure 30: North America Amniotic Membrane Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: Europe Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 32: Europe Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 33: Europe Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027

Figure 34: Europe Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 35: Europe Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 36: Europe Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 37: Europe Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027

Figure 38: Europe Amniotic Membrane Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027

Figure 39: Europe Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 40: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 41: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 42: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Product, 2017–2027

Figure 43: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 44: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 45: Asia Pacific Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 46: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027

Figure 47: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 48: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 49: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Latin America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 51: Latin America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027

Figure 52: Latin America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 53: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 54: Latin America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 55: Latin America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027

Figure 56: Latin America Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 57: Latin America Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 58: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 59: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027

Figure 60: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027

Figure 61: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027

Figure 62: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027

Figure 63: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027

Figure 64: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by End User, 2019?2027

Figure 65: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 66: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 67: Global Amniotic Membrane Market Share, by Company, 2018

Figure 68: Integra LifeSciences Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 69: Integra LifeSciences Breakdown of Net Sales, by Geography, 2018

Figure 70: Integra LifeSciences Breakdown of Net Sales, by Product Segment, 2018

Figure 71: Integra LifeSciences R&D Intensity and Sales & Marketing Intensity (%), 2015–2018

Figure 72: MiMedx Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 73: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 74: Stryker Breakdown of Net Sales (%), by Region/Country, 2018

Figure 75: Stryker Breakdown of Net Sales (%), by Product Segment, 2018

Figure 76: Stryker R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 77: Osiris Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 78: Osiris Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 79: Osiris Therapeutics, Inc. Breakdown of Net Sales (%), by Product Segment, 2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

776

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved